Bernhard Nilica

68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

Francesco Ceci, Christian Uprimny, Bernhard Nilica et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 260 citations

Medicine, Nuclear Medicine, Radiology +16

68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT

Alexander Kroiss, Daniel Putzer, Clemens Decristoforo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 106 citations

Medicine, Nuclear Medicine, Oncology +17

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 98 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +16

Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 93 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

68Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to 123I-MIBG SPECT/CT

Alexander Kroiss, Barry L. Shulkin, Christian Uprimny et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 57 citations

Medicine, Nuclear Medicine, Radiology +12